{"id":"https://openalex.org/W4394547840","doi":"https://doi.org/10.6084/m9.figshare.7677878","title":"Hormone receptor-negative as a predictive factor for pathologic complete response to neoadjuvant therapy in breast cancer","display_name":"Hormone receptor-negative as a predictive factor for pathologic complete response to neoadjuvant therapy in breast cancer","publication_year":2019,"publication_date":"2019-01-01","ids":{"openalex":"https://openalex.org/W4394547840","doi":"https://doi.org/10.6084/m9.figshare.7677878"},"language":"en","primary_location":{"id":"pmh:oai:figshare.com:article/7677878","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/dataset/Hormone_receptor-negative_as_a_predictive_factor_for_pathologic_complete_response_to_neoadjuvant_therapy_in_breast_cancer/7677878","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Dataset"},"volume":null,"type":"dataset","is_traditional":false,"indexed_in":["datacite"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://figshare.com/articles/dataset/Hormone_receptor-negative_as_a_predictive_factor_for_pathologic_complete_response_to_neoadjuvant_therapy_in_breast_cancer/7677878","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5083225950","display_name":"Luana Carolina Ferreira Fiuza Silva","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Silva, Luana Carolina Ferreira Fiuza","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023708293","display_name":"Lilian Martins Arruda","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Arruda, Lilian Silva Martins De","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069295777","display_name":"Waldec Jorge David Filho","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Waldec Jorge David Filho","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035787523","display_name":"Felipe Jos\u00e9 Silva Melo Cruz","orcid":"https://orcid.org/0000-0002-4558-4850","observed_orcids":["https://orcid.org/0000-0002-4558-4850","https://orcid.org/0000-0002-4189-3082"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Cruz, Felipe Jos\u00e9 Silva Melo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007160664","display_name":"Damila Cristina Trufelli","orcid":"https://orcid.org/0000-0001-7322-7482","observed_orcids":["https://orcid.org/0000-0001-7322-7482"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Damila Cristina Trufelli","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5077080268","display_name":"Auro del Giglio","orcid":"https://orcid.org/0000-0002-2009-824X","observed_orcids":["https://orcid.org/0000-0002-2009-824X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Giglio, Auro Del","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11134","display_name":"Breast Lesions and Carcinomas","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11885","display_name":"MRI in cancer diagnosis","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hormone-receptor-negative-breast-cancer","display_name":"hormone receptor-negative breast cancer","score":0.9419999718666077},{"id":"https://openalex.org/keywords/pathological-complete-response","display_name":"pathological complete response","score":0.9879999756813049},{"id":"https://openalex.org/keywords/neoadjuvant-chemotherapy","display_name":"neoadjuvant chemotherapy","score":0.9959999918937683},{"id":"https://openalex.org/keywords/locally-advanced-breast-cancer","display_name":"locally advanced breast cancer","score":0.9390000104904175},{"id":"https://openalex.org/keywords/predictive-factors","display_name":"predictive factors","score":0.7570000290870667},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.9539999961853027},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.8190000057220459},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9990000128746033},{"id":"https://openalex.org/keywords/her2-status","display_name":"HER2 status","score":0.9229999780654907},{"id":"https://openalex.org/keywords/histologic-grade","display_name":"histologic grade","score":0.7490000128746033},{"id":"https://openalex.org/keywords/lymph-node-metastasis","display_name":"lymph node metastasis","score":0.7860000133514404}],"concepts":[{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.7426198720932007},{"id":"https://openalex.org/C2778292576","wikidata":"https://www.wikidata.org/wiki/Q6991934","display_name":"Neoadjuvant therapy","level":4,"score":0.6294256448745728},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6014572978019714},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5692178606987},{"id":"https://openalex.org/C3019096185","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Complete response","level":3,"score":0.5418539643287659},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4987804889678955},{"id":"https://openalex.org/C2780275930","wikidata":"https://www.wikidata.org/wiki/Q1628266","display_name":"Hormone therapy","level":4,"score":0.49255117774009705},{"id":"https://openalex.org/C23589133","wikidata":"https://www.wikidata.org/wiki/Q412005","display_name":"Hormone receptor","level":4,"score":0.4522344768047333},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.39810752868652344},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.1792941391468048}],"mesh":[],"locations_count":3,"locations":[{"id":"pmh:oai:figshare.com:article/7677878","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/dataset/Hormone_receptor-negative_as_a_predictive_factor_for_pathologic_complete_response_to_neoadjuvant_therapy_in_breast_cancer/7677878","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Dataset"},{"id":"doi:10.6084/m9.figshare.7677878","doi":"https://doi.org/10.6084/m9.figshare.7677878","is_oa":true,"landing_page_url":"https://doi.org/10.6084/m9.figshare.7677878","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Dataset"},{"id":"doi:10.6084/m9.figshare.7677878.v1","doi":"https://doi.org/10.6084/m9.figshare.7677878.v1","is_oa":true,"landing_page_url":"https://doi.org/10.6084/m9.figshare.7677878.v1","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Dataset"}],"best_oa_location":{"id":"pmh:oai:figshare.com:article/7677878","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/dataset/Hormone_receptor-negative_as_a_predictive_factor_for_pathologic_complete_response_to_neoadjuvant_therapy_in_breast_cancer/7677878","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Dataset"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2076903579","https://openalex.org/W2022938615","https://openalex.org/W4391219146","https://openalex.org/W4394387859","https://openalex.org/W2094718541","https://openalex.org/W7223051653","https://openalex.org/W4413788218","https://openalex.org/W7171981281","https://openalex.org/W2241955289","https://openalex.org/W7166890483"],"abstract_inverted_index":{"ABSTRACT":[0],"Objective":[1],"To":[2],"define":[3],"a":[4,32,106,227],"predictive":[5,205],"factor":[6,34,215,229],"for":[7,35,216,230],"pathologic":[8,20,28,93,133,164,190,207],"complete":[9,29,94,134,165,191,208,224],"response,":[10,95,103,111],"compare":[11],"the":[12,17,81,88,98,160,168,176],"oncologic":[13],"outcomes":[14],"associated":[15],"with":[16,60,136],"degree":[18],"of":[19,45,80,87,100,132,163,170,206],"response":[21,30,135,166,192,209,225],"after":[22,157],"neoadjuvant":[23],"chemotherapy,":[24],"and":[25,38,53,71,77,109,152,189,210,220],"to":[26,48,58,119],"analyze":[27],"as":[31,105,184,195],"prognostic":[33,177],"overall":[36,221],"survival":[37,219,233],"progression-free":[39,218],"survival.":[40,222],"Methods":[41],"A":[42],"retrospective":[43],"study":[44,124],"patients":[46],"admitted":[47],"Hospital":[49,54],"Estadual":[50],"M\u00e1rio":[51],"Covas":[52],"Anchieta":[55],"from":[56],"2008":[57],"2012,":[59],"locally":[61],"advanced":[62,154],"breast":[63],"cancer.":[64],"Hormone":[65,201],"receptor":[66,145,180,202],"status,":[67,69],"HER2":[68],"histologic":[70],"nuclear":[72],"grade,":[73],"age":[74,151],"upon":[75],"diagnosis":[76],"histological":[78,139],"type":[79],"tumor":[82,89],"were":[83,117],"analyzed.":[84],"Pathologic":[85,223],"evaluation":[86],"was":[90,129,167,182,193],"subdivided":[91],"into":[92],"defined":[96],"by":[97],"absence":[99],"tumor;":[101],"intermediate":[102],"considered":[104,183,194],"favorable":[107],"stage;":[108],"poor":[110],"considering":[112],"low-responder":[113],"patients.":[114,127],"Data":[115],"obtained":[116],"submitted":[118],"statistical":[120],"analysis.":[121],"Results":[122],"The":[123],"included":[125],"243":[126],"There":[128],"an":[130,185,196,212],"association":[131],"HER-2":[137],"negative,":[138,146],"grade":[140],"3,":[141],"stage":[142],"III,":[143],"hormone":[144,172,179],"positive":[147],"lymph":[148],"node,":[149],"older":[150],"more":[153],"tumors.":[155],"However,":[156],"multivariate":[158],"analysis":[159],"only":[161],"predictor":[162],"presence":[169],"negative":[171,181,203],"receptor.":[173],"By":[174],"analyzing":[175],"factors,":[178],"independent":[186,197],"risk":[187,214],"factor,":[188],"protective":[198,228],"factor.":[199],"Conclusion":[200],"is":[204,211,226],"isolated":[213],"lower":[217],"these":[231],"same":[232],"analyses.":[234]},"counts_by_year":[],"updated_date":"2026-10-08T09:06:37.294493","created_date":"2024-04-08T00:00:00"}